Clinical trial
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
NCT00616070 is registered in ClinicalTrials.gov with Sirion Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
- Lead sponsor
- Sirion Therapeutics, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- March 31, 2008
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.